By Professor Ric Day

Conference Abstracts

Knock E; Ezard N; Day R; Siefried KJ; Liknaitzky P; Ross M; Albert S; Brett J, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS', in NEPHROLOGY, WILEY, Vol. 27, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Juhl CB; Simic M; Pihl K; Berthelsen DB; Day R; Koes B; Thorlund JB, 2022, 'COMPARISON OF EXERCISE THERAPY, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, AND OPIOIDS FOR KNEE OSTEOARTHRITIS PAIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, GERMANY, Berlin, Vol. 30, pp. S65 - S66, presented at OARSI World Congress on Osteoarthritis, GERMANY, Berlin, 07 April 2022 - 10 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000775103700081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Green EAE; Yee SW; Rashkin SR; Witte J; Shin JG; Klovins J; Stocker S; Day R; Giacomini KM, 2019, 'GENETIC DETERMINANTS OF METFORMIN PHARM-ACOKINETICS: A METFORMIN GENETIC CONSORTIUM COLLABORATION.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S36 - S36, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shingde R; Graham G; Reuter S; Carland J; Williams K; Day R; Stocker S, 2019, 'PREDICTIVE PERFORMANCE OF A COMMERCIAL BAYESIAN FORECASTING PROGRAM IN ESTIMATING VANCOMYCIN DRUG EXPOSURE.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S38 - S38, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stocker SL; Carland JE; Moran MA; Tang S; Li CY; Alin JS; Gilbey T; Graham GG; Williams KM; Marriott DJ; Day RO, 2018, 'A CLINICAL EVALUATION OF VANCOMYCIN DOSING AND MONITORING.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, FL, Orlando, Vol. 103, pp. S88 - S88, presented at 119th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) - Breaking Down Barriers to Effective Patient Care, FL, Orlando, 21 March 2018 - 24 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424997100316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kamel B; Stocker S; Graham G; Carland J; Parker M; Williams K; Pile K; Portek I; McGill N; Day R, 2017, 'A MULTICENTRE OPEN-LABEL PHARMACOKINETIC-PHARMACODYNAMIC (PKPD) STUDY OF FEBUXOSTAT IN PATIENTS WITH CHRONIC GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 47, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Norton R; Woodward M; Day R; Fransen M, 2016, 'CLINICAL PREDICTORS OF MEDIAL KNEE OSTEOARTHRITIS PROGRESSION OVER 2 YEARS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, Amsterdam, NETHERLANDS, Vol. 24, pp. S220 - S220, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis, Amsterdam, NETHERLANDS, 31 March 2016 - 03 April 2016, http://dx.doi.org/10.1016/j.joca.2016.01.424

Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day RO; McLachlan AJ; Hunter DJ; Ferreira ML, 2016, 'EFFICACY AND SAFETY OF PARACETAMOL COMPARED TO PLACEBO FOR KNEE AND HIP OSTEOARTHRITIS: A COCHRANE SYSTEMATIC REVIEW', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, Vol. 24, pp. S44 - S44, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis, NETHERLANDS, Amsterdam, 31 March 2016 - 03 April 2016, http://dx.doi.org/10.1016/j.joca.2016.01.104

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2015, 'IDENTIFYING BARRIERS TO TREATING GOUT EFFECTIVELY: A QUALITATIVE STUDY OF PATIENTS' AND GENERAL PRACTITIONERS' UNDERSTANDING AND MANAGEMENT OF GOUT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen A; Baysari M; Kannangara D; Tariq A; Lau A; Westbrook J; Day R, 2015, 'MOBILE APPS TO ENHANCE SELF-MANAGEMENT OF GOUT: CONCORDANCE WITH MANAGEMENT GUIDELINES', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Day R; Williams K; Phipps-Green A; Dalbeth N; Stamp L; Merriman T, 2015, 'THE URATE TRANSPORTER ABCG2 AND THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU): CHANGING THE WAY WE THINK ABOUT HYPERURICAEMIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Graham G; Wright D; Barclay M; Stamp L; Williams K; Day R, 2015, 'TREATING GOUT PATIENTS WITH ALLOPURINOL: A CONCENTRATION- OR DOSE-RESPONSE APPROACH?', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day RO, 2014, 'GLUCOSAMINE AND CHONDROMN FOR KNEE OSTEOARTHRITIS: A DOUBLE BLIND RANDOMISED CONTROLLED CLINICAL TRIAL EVALUATING SINGLE AND COMBINATION REGIMENS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, FRANCE, Paris, Vol. 22, pp. S457 - S457, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI), FRANCE, Paris, 24 April 2014 - 27 April 2014, http://dx.doi.org/10.1016/j.joca.2014.02.868

Milder T; Lipworth W; Ritchie J; Williams K; Day R, 2011, 'WHAT DRIVES OSTEOARTHRITIS PATIENTS TO USE OR NOT USE NSAIDS, PARACETAMOL AND COMPLEMENTARY MEDICATIONS?', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 41, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Williams KM; March LM; Bertouch JV; Day RO, 2004, 'Subsided access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?', in Medical Journal of Australia, Australasian Med Publishing Company Ltd, Vol. 181, pp. 457 - 457

Williams KM; Cooper S; Parisis K; Handel M; Day RO, 2001, 'The skin suction blister: A human model of inflammation', in Clinical Pharmacology and Therapeutics, Vol. 69

Williams KM; Mclachlan AJ; Day RO; Pritchard A, 1998, 'Comparative pharmacokinetics of hepatitis B immuno-globulin after intramuscular administration in healthy subjects', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 285, presented at Archives of Pharmacology 358, Munich, Germany

Day RO; Mclachlan AJ; Williams KM, 1998, 'Population pharmacokinetics (PK) and pharmacodynamics (PD) of tenoxicam (TN) in patients with rheumatoid arthritis (RA)', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 168, presented at Clinical and Pharmacology Therapeutics

Williams KM; Turner J; Geisslinger G; Day RO, 1997, 'The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 61, pp. PI93 - PI93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WJ68400093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; NGUYEN T; WILLIAMS KM, 1993, 'TENOXICAM DOSE CONCENTRATION RESPONSE RELATIONSHIP IN RHEUMATOID-ARTHRITIS (RA)', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 53, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KP26900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page